Overview

Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant Users

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the abuse potential of AZD7325.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Central Nervous System Depressants
Lorazepam